Rapid Micro Biosystems, Inc. Class A RPID 深 沪
交易中 11-05 10:22:36 美东时间
0.67
-0.011
-1.67%
华盛通- 最 高0.7086
- 今 开0.69
- 成交量 1.91万股
- 最 低 0.67
- 昨 收 0.6814
- 总市值 3360.69万
- 52周最高 4.94
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 0.6546
- 委 比 66.67%
- 总股本 5015.96万
- 历史最高 27.04
- 量 比 1.53
- 振 幅 5.66%
- 历史最低 0.58
- 每 手 1
- 风险率 1.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅11184.05%！如瑞迪博士获花旗上调目标价至1450美元，维持"买入"评级
今日重点评级关注：花旗：上调如瑞迪博士"买入"评级，目标价从1040美元升至1450美元；加拿大帝国商业银行：维持Inventiva"买入"评级，目标价从20美元升至21美元
09-30 08:33
Roth Capital Initiates Coverage On Rapid Micro Biosystems with Buy Rating, Announces Price Target of $3
Roth Capital analyst Max Masucci initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Buy rating and announces Price Target of $3.
09-29 18:06
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.133 million estimate.
08-07 19:01
Rapid Micro Biosystems Q2 EPS $(0.27) Misses $(0.24) Estimate, Sales $8.054M Beat $7.875M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.24) by 12.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $8.054 million which beat the analyst consensus estima...
08-07 19:01
美股大行评级 | Susquehanna上调美光目标价从600美元升至1750美元；戴尔、MongoDB、网泰信息存储、Nextpower、Okta等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从7美元升至7.5美元；Susquehanna：维持美光科技"积极"评级，目标价从600美元升至1750美元
06-01 14:11
Keybanc Maintains Overweight on Rapid Micro Biosystems, Lowers Price Target to $5
Keybanc analyst Paul Knight maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight and lowers the price target from $8 to $5.
05-29 23:49
Lake Street Maintains Buy on Rapid Micro Biosystems, Lowers Price Target to $7
Lake Street analyst Thomas Flaten maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Buy and lowers the price target from $8 to $7.
05-22 23:02
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
Rapid Micro Biosystems (NASDAQ:RPID) released first-quarter financial results a...
05-14 05:31
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.225M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.225 million estimate.
05-14 04:34
Rapid Micro Biosystems Q1 EPS $(0.31) Misses $(0.23) Estimate, Sales $8.002M Beat $7.600M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 19.23 percent decrease over losses of $(0.26) per
05-14 04:33
